Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
A compound, C1-C12 technology, applied in the field of compounds that inhibit the activity of PI3 kinase, which can solve the problems of impaired signal transduction, B cell proliferation and loss of signal transduction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0420] Preparation of compounds of formula I
[0421] Compounds of formula I can be synthesized by synthetic routes including methods analogous to those well known in the chemical arts, in particular according to those methods described for heterocycles contained in this application and in the literature below, which In: Comprehensive Heterocyclic Chemistry II, Editors Katritzky and Rees, Elsevier, 1997, e.g. Volume 3; Liebigs Annalen der Chemie, (9): 1910-16, (1985); Helvetica Chimica Acta, 41: 1052-60, (1958) ; Arzneimittel-Forschung, 40(12): 1328-31, (1990), each of which is expressly incorporated herein by reference. Starting materials are typically obtained from commercial sources (e.g., Aldrich Chemicals (Milwaukee, WI)) or readily prepared using methods well known to those skilled in the art (e.g., by methods generally described in Louis F. Fieser and Mary Fieser, Reagents for Organic Synthesis, v. 1-23, Wiley, N.Y. (1967-2006 ed.), or Beilsteins Handbuchder organische...
Embodiment 1
[0497] Example 1 3-(Tetrahydropyran-4-yl)azetidine-1-carboxylate tert-butyl ester
[0498]
[0499] Step 1: 3,6-Dihydro-2H-pyran-4-yl trifluoromethanesulfonate
[0500]
[0501] To a solution of diisopropylamine (35.2 mL, 0.25 mol) in dry THF (200 mL) was added 2.5 M n-butyllithium in hexanes (100 mL) over 10 min at -20 °C under argon atmosphere , 0.25mol). The reaction mixture was stirred at -20°C for 15 minutes. A solution of tetrahydropyran-4-one (21.0 mL, 0.23 mol) in dry THF (160 mL) was added dropwise over 20 minutes (internal temperature 2 SO 4 Drying, filtration and concentration gave 3,6-dihydro-2H-pyran-4-yl trifluoromethanesulfonate as a brown oil (43.7 g, 83%). 1 H NMR (400MHz, CHCl 3 -d): δ5.83-5.80 (m, 1H); 4.26 (dd, J=2.9, 0.4Hz, 2H); 3.89 (t, J=5.5Hz, 2H); 2.46 (ttd, J=5.5, 2.9 , 1.4Hz, 2H).
[0502] Step 2: tert-Butyl 3-(3,6-Dihydro-2H-pyran-4-yl)azetidine-1-carboxylate
[0503]
[0504] Zinc activation: to zinc powder (20.3 g, 0.31 mol) an...
Embodiment 2
[0509] Example 2 (4-Methylpiperidin-4-yl)pyrrolidin-1-ylmethanone
[0510]
[0511] Step 1: tert-butyl 4-methyl-4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylate
[0512]
[0513] To a solution of 4-methylpiperidine-1,4-dicarboxylate mono-tert-butyl ester (229 mg, 0.94 mmol) in DMF (10 mL) was added DIPEA (0.493 mL, 2.83 mmol), pyrrolidine (0.118 mL) , 1.41 mmol) and HATU (537 mg, 1.41 mmol). The reaction mixture was stirred at room temperature for 18 hours, then partitioned between water and EtOAc. The organic layer was separated, washed with 0.1N aqueous HCl and brine, washed with Na 2 SO 4 Drying, filtration and concentration gave tert-butyl 4-methyl-4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylate as a white solid (279 mg, 100%). LCMS (Method H): R T is 4.00 minutes; [M+Na] + 319.
[0514] Step 2: tert-butyl 4-methyl-4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylate (296 mg, 1.0 mmol) in TFA (5 mL), DCM (5 mL) and water (0.1 mL) ) was stirred at room ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com